Position in ANNX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$6,824,260
-$905,141 QoQ
Shares Held
1,195,142
-52.8% QoQ
Ownership
0.585%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#31
of 216 holders
Holding Since
Sep 2022
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ANNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Candriam S.C.A. holds $2,107,868,027 across 75 Biotechnology names. ANNX ranks #68 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
195,674 | $122,010,565 | |
| 2 | RVMD |
Revolution Medicines, Inc.
|
556,392 | $104,201,093 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
199,505 | $99,100,118 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
314,512 | $94,677,547 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
289,735 | $82,565,782 | |
| 6 | COGT |
Cogent Biosciences, Inc.
|
2,088,369 | $80,819,880 | |
| 7 | ARGX |
Argenx SE
|
80,120 | $74,332,932 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
1,990,510 | $70,444,148 |
All Filings in ANNX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,824,260 | 1,195,142 | Shares | Sole | 2026-08-13 | |
| 2025-09-30 | $7,729,401 | 2,534,230 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $6,082,152 | 2,534,230 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $4,891,063 | 2,534,230 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $13,000,599 | 2,534,230 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $12,981,370 | 2,192,799 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $10,061,949 | 2,053,459 | Shares | Sole | 2024-08-05 | |
| 2022-12-31 | $850,764 | 164,558 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,023,099 | 165,550 | Shares | Sole | 2022-11-10 | |
| No filing history on record for this holder in this stock. | ||||||